FOXM1 and glioblastoma: For example, pGENMi reported FOXM1 as a top scoring association for the drug temozolomide; this prediction was validated by a study where siRNA knockdown of FOXM1 was shown to sensitize recurrent glioblastoma multiforme (GBM) tumors to this drug (Zhang et al. 2012).